Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsGlenmarkpharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Podcast | Stock picks of the day: 11,500 important support for Nifty; here are 3 top buy ideas

      If Nifty fails to regain 11,720 in the coming week, it may trigger further selling pressure. Important support for Nifty is seen around the 11,500.

    • 'Nifty Bank likely to see resistance at 32,000; deploy Bull Call Spread'

      Bank Nifty options data for upcoming weekly expiry depicts 31,000 as strong support as aggressive Put writing is seen at 31,000 and on upside the highest Call OI is at 32,000, which can act as strong resistance

    • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

      Ashwani Gujral of ashwanigujral.com recommends buying Indraprastha Gas with a stop loss of Rs 320, target of Rs 345, Hindustan Unilever with a stop loss of Rs 1730, target of Rs 1765 and Titan Company with a stop loss of Rs 1110, target of Rs 1140.

    • Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

      Sudarshan Sukhani of s2analytics.com recommends buying Infosys with stop loss at Rs 734 and target of Rs 760, Manappuram Finance with stop loss at Rs 117 and target of Rs 126 and Bata India with stop loss at Rs 1346 and target of Rs 1380.

    • Goldman Sachs positive on value cyclicals & quality midcaps, lists 15 favourites

      The global investment bank expects returns to be driven largely by earnings with potential valuation overshoot in the near-term.

    • Buy Glenmark Pharma above Rs 658: Shabbir Kayyumi

      Positional trader can create fresh long position above Rs 658 with a stop below Rs 635 on closing basis for an initial target of Rs 715.

    • A breach of 10,720 can take Nifty to 10,550: Narnolia

      A breakout of descending trend line on lower time frame will occur only above 10,881, suggesting a tight range for the index—10720 to 10881

    • Technical View | Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

      Sudarshan Sukhani of s2analytics.com recommends buying Bata India with stop loss at Rs 1145 and target of Rs 1170, Berger Paints with stop loss at Rs 322 and target of Rs 331 and HCL Tech with stop loss at Rs 955 and target of Rs 980.

    • Technical View | Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

      Sudarshan Sukhani of s2analytics.com recommends buying Bata India with stop loss at Rs 1150 and target of Rs 1185, NIIT Tech with stop loss at Rs 1170 and target of Rs 1210 and RBL Bank with stop loss at Rs 568 and target of Rs 585.

    • Elara Capital is betting on these companies for a robust Q3 performance

      Elara said NBFCs are expected to bear the brunt of tightening liquidity, down 18.6 percent YoY, whereas banks would benefit, up 69 percent YoY, due to improving credit deposit ratios and improvement in pricing power, given the stress in the NBFC space.

    • Buy Glenmark Pharma, says Sumit Bilgaiyan

      During Q2FY19, its net profit increased by 93.32 percent to Rs 414 crore from Rs 214.12 crore on YoY basis on 14.23 percent higher sales of Rs 2539.86 crore.

    • Technical Views | Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

      Mitessh Thakkar of miteshthacker.com recommends buying Cummins India with a stop loss below Rs 839 for target of Rs 900, Glenmark Pharma with a stop loss of Rs 685 and target of Rs 720 and M&M with a stop loss of Rs 792 and target of Rs 830.

    • Confident of midcap and smallcap rally in first half of 2019: Bilgaiyan

      For the next week, Nifty has strong support around 10,800-10,745 and resistance around 10,965-11,090

    • Buy Glenmark Pharma with 8% return: Aditya Agarwal

      The stock formed a higher highs pattern which is a bullish setup. The daily RSI (14) entered above 60 levels which is a bullish signal.

    • Technical Views | Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

      Mitessh Thakkar of mitesshthakkar.com suggests buying India Cements with a stop loss of Rs 95 and target of Rs 103, Lupin with a stop loss of Rs 882 and target of Rs 945 and DCB Bank with a stop loss of Rs 157.5 and target of Rs 169.

    • Buy Glenmark Pharma with target Rs 695: Shabbir Kayyumi

      Take long position in the stock around Rs 645 with a stop loss Rs 630.

    • Cautious on market ahead of RBI credit policy, OPEC meeting; top 5 buys for 6-12% returns

      Key resistance on the upside is 100-day moving average around 10,950 and mark of 11,085 which is 61.8 percent retracement of 1,700 points fall during September-October, said Shabbir Kayyumi of Narnolia Financial Advisors

    • Stock picks of the day: Resistance for Nifty around 10,690, volatility expected in short term

      Given a strong rebound in the last session to hold above 10,550 levels, the immediate resistance for the index is placed at 10,616 levels followed by 10,690 level and support is seen at 10,450 levels.

    • Buy or sell: Top stock trading ideas by market experts which are good short-term bets

      Rajesh Agarwal of AUM Capital recommends buying Voltas with stop loss at Rs 523 and target of Rs 560, RBL Bank with stop loss at Rs 544 and target of Rs 562 and Strides Pharma Science with stop loss at Rs 462 and target of Rs 495.

    • Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for Muhurat Trading Day

      Sudarshan Sukhani of s2analytics.com advises buying Reliance Industries with a target of Rs 1132.

    • Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term

      Sudarshan Sukhani of s2analytics.com suggests buying Colgate Palmolive with stop loss of Rs 1120 and target of Rs 1135, Glenmark Pharma with stop loss at Rs 606 and target of Rs 636 and Havells India with stop loss at Rs 585 and target of Rs 630.

    • Take long position in Glenmark Pharma: Shabbir Kayyumi

      One can take long position in the stock at Rs 585 with stop loss of Rs 548 for the target of Rs 660 levels.

    • Weakness to continue in short term; 5 stock to bet on for double-digit returns

      A breakout is expected to come only above 10,520-10,540 zone from where it can extend up to 10,750 & 10,850 levels.

    • Bank of America Merrill Lynch hikes Glenmark Pharma’s target to Rs 715

      The stock has been rerated on the back of recent deals, which could lead to expectations of reduction in debt.

    • Top buy & sell ideas by Ashwani Gujral, Sudarshan Sukhani, Prakash Gaba for short term

      Prakash Gaba of prakashgaba.com suggests buying India Cements with target at Rs 133 and stop loss at Rs 124, ITC with target at Rs 325 and stop loss at Rs 315 and Sun Pharma Advanced with target at Rs 425 and stop loss at Rs 390.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347